Iranian Journal of Medical Sciences

Document Type : Original Article(s)

Authors

1 Department of MPH, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

2 Student Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Abstract

Background: Alcohol, smoking, and substance use among medical students are significant health concerns that impact their well-being and their future roles as health advocates. This study aimed to investigate the prevalence of these behaviors and related risk factors among medical students in southern Iran.
Methods: This cross-sectional study was conducted among medical students in Shiraz, in southern Iran, in 2024. Data were collected using the World Health Organization’s alcohol, smoking, and substance involvement screening test (ASSIST), supplemented with questions on demographic details, family and friend substance use, mental health, and major satisfaction. The sample was selected using the stratified random selection method. Logistic regression models were used to identify factors associated with substance use, controlling for potential confounders. P<0.05 was considered statistically significant. All analyses were performed using SPSS software (version 26, SPSS Inc., USA).
Results: The study included 360 medical students, of whom 51.9% were men, with a mean age of 22.62±3.02 years. The lifetime prevalence was 27.5% for alcoholic beverages, 26.7% for tobacco products, 14.4% for sedatives or sleeping pills, and 15.8% for electronic cigarettes and vapes. Logistic regressions analysis revealed that having a family member who uses substances (OR=1.8, 95% CI:1.01-3.5), having a friend who uses substances (OR=3.9, 95% CI: 2.0-7.8), being male (OR=1.8, 95% CI: 1.03-3.2), and having a recent history of mental illnesses (OR=2.8, 95% CI: 1.1-7.1) were positively associated with lifetime cigarette use.
Conclusion: The prevalence of alcohol, smoking, and substance use among medical students in southern Iran is concerning. These findings emphasized the significance of targeted interventions to reduce and prevent use within this population. 

Highlights

Seyed Ali Mansouri (Google Scholar)
Alireza Salehi (Google Scholar)

Keywords

What’s Known

Studies conducted in Iran have reported a wide range of cigarette smoking prevalence among medical students, with rates varying from 10.5% to 46.7%. Regarding alcohol consumption, prevalence rates of 18.3%, 19.9%, and 13% have been reported among medical students in Iran.

What’s New

The lifetime prevalence of substance use was 27.5% for alcoholic beverages and 26.7% for tobacco products. Significant associations were identified between substance use and the students’ stage of training, economic status, history of mental illness, history of substance use in family and friends, electronic device use, and satisfaction with their major.

Introduction

The issue of alcohol, smoking, and substance (ASS) is a complex global health issue with extensive detrimental consequences for individuals, families, and society. According to the World Health Organization (WHO), smoking is the second leading cause of death worldwide. 1 Tobacco use is estimated to cause more than six million deaths annually, a figure forecast to rise to over eight million by 2030. 2 Similarly, alcohol consumption is a significant risk factor for physical and mental disorders and is also associated with various cancers and other health-related fatalities. 3 The rising prevalence of ASS use among university students is a growing concern, particularly among medical students, who are expected to uphold high standards as future advocates and promoters of well-being. 4

A study in Iran reported prevalence rates of 14% for smoking, 9% for alcohol use, and 11% for drug use. 5 Epidemiological studies indicated that young people and university students have a higher prevalence of illicit ASS use than other age groups. 6 Among medical students specifically, previous studies in Iran showed a wide variation in ASS use prevalence, ranging from 10.5% to 46.7%. 7 , 8 A meta-analysis of Iranian university students reported one-year prevalence rates of 23% (95% CI: 8-39) for alcohol consumption, 21% (95% CI: 6-37) for cigarette smoking, and 14% (95% CI: 10-18) for other substance use. 9 Furthermore, factors such as stress, academic pressure, peer influence, and social norms have been identified as contributors to increased smoking and drug use among medical students. Personal characteristics, such as sex, age, and a family history of substance use, were also found to be associated with these behaviors. 10 , 11

The harmful effects of ASS involvement on students’ health, academic performance, and well-being are well-documented. 12 Investigating the situation is therefore essential for informed planning. Epidemiological studies are widely considered the foundational step for designing preventive programs. By examining the prevalence, patterns, and associated factors, we can gain valuable insights into these behaviors among medical students. The resulting data are instrumental for developing targeted interventions and prevention strategies to promote healthier lifestyles. Given the varied findings of previous research and growing concern about ASS use among medical students, a detailed exploration in this field is warranted. This study was conducted at Shiraz University of Medical Sciences in southern Iran, which has a large and diverse student population that enhances the generalizability of the findings. The university’s prominent role in regional medical education further supports the reliability and applicability of the results to similar contexts and populations. 13 Therefore, this study aimed to investigate the prevalence of ASS use and its related risk factors among medical students in southern Iran in 2024.

Participants and Methods

Study Design

This cross-sectional study was conducted in 2024 among medical students at Shiraz University of Medical Sciences in Shiraz, southern Iran. A total of 360 students were recruited. The study protocol was approved by the Ethics Committee of Shiraz University of Medical Sciences (code: IR.SUMS.MED.REC.1403.245). All participants provided written informed consent, and the study adhered to ethical principles to ensure participant confidentiality and privacy.

Participants

Eligible participants were medical students enrolled at Shiraz University of Medical Sciences for at least 3 months. Students at the residency level or above, transfer students, and those with incomplete or defective data were excluded from the study.

Instruments

Data were collected using a written questionnaire consisting of three parts: demographic information, the World Health Organization’s alcohol, smoking, and substance involvement screening test (ASSIST), and questions on factors associated with substance use. The ASSIST instrument investigated involvement with various substances, including tobacco products, alcoholic beverages, opioids, cannabis, amphetamine-type stimulants, sedative or sleeping pills, inhalants, hallucinogens, cocaine, and other substances, collectively referred to as ASS in this study. The questions covered the frequency of ASS use over the past 3 months and lifetime use. The instrument also assessed several domains, including the desire to use, the impact of use on health, social, legal, or financial aspects, concern from close relations, difficulties in performing expected tasks, unsuccessful efforts to quit or reduce use, and any history of intravenous drug use. 14

The ASSIST questionnaire included questions with numerically scored response options. Questions 2-5 assessed the frequency of substance use, with response options of “never”, “once or twice”, “monthly”, “weekly”, or “daily or almost daily”. The scores for each question were as follows: Q2: 0, 2, 3, 4, 6; Q3: 0, 3, 4, 5, 6; Q4: 0, 4, 5, 6, 7; Q5: 0, 5, 6, 7, 8. Questions 6 and 7 ask about experiencing problems related to substance use, with the options: “no, never” (score 0), “yes, but not in the past 3 months” (score 3), or “yes, in the past 3 months” (score 6). The interviewer recorded the scores for questions 2 to 7, which were subsequently totaled for each substance to generate an overall risk score. This score was categorized into three risk levels: “Low” (a score of 3 or less, or 10 or less for alcohol), “moderate” (4-26, or 11-26 for alcohol), and “high” (27 or higher).

The ASSIST instrument has undergone three primary stages of testing, confirming its reliability, validity in international contexts, and its suitability for integration into brief intervention strategies. 15 , 16 Additionally, Hooshyari and colleagues assessed the validity and reliability of the Persian translation of this test in Iran, reporting a Cronbach’s alpha between 0.79 and 0.95 for the entire test and its subscales, indicating high internal consistency. 17

For the present study, content validity was assessed using the content validity ratio (CVR) and content validity index (CVI). Fifteen experts, including physicians and sociologists with relevant research experience, reviewed the items. They rated each item on a three-point scale for essentiality. Based on Lawshe’s table, a minimum CVR threshold of 0.51 was applied, calculated using the formula:

CVR=(Ne-N/2)/(N/2)

Where Ne is the number of experts rating the item as “essential”. Items with a CVR below this threshold were eliminated, resulting in a final CVR of 0.75 for the remaining items. To assess relevance, experts also scored items on a four-point scale. The CVI was calculated as the average of these scores across items, yielding a value of 0.85. All items were retained after this process, as a CVI above 0.80 is generally considered acceptable. Face validity was confirmed by experts in substance use, who verified that the questions accurately reflect students’ experiences with substance-related issues. The overall content validity assessment confirmed that the questionnaire comprehensively addresses key aspects of substance use. Experts validated that the items covered critical dimensions of substance use, enhancing the questionnaire’s reliability and effectiveness in capturing relevant data for the study.

The use of electronic cigarettes and vapes was investigated using specific survey questions. Participants were asked to report the frequency of their use both over their lifetime and within the past 3 months.

Sampling Process

A stratified random sampling method was employed. The student population was divided into strata based on their academic year (basic sciences, pre-clinic, and clinic) to ensure representation across key subgroups. A random sample was then selected from each stratum.

The sample size was calculated using the following formula:

n=Z2P(1−P)/d2

With a 95% confidence level (Z), an expected prevalence (P) of 40% derived from a pilot study, and a precision (d) of 0.05. The Kaiser-Meyer-Olkin measure of sampling adequacy was above 0.7, confirming the sample’s suitability for factor analysis.

Data were collected via paper-based, self-administered surveys, distributed in lecture halls during class time. The surveys took approximately 10-15 min to complete. To ensure anonymity and confidentiality, completed surveys were deposited by students into a sealed ballot box, and researchers had no access to participant identities. Participation was voluntary, and students could withdraw at any time without penalty.

Due to a low percentage of missing data (<2%), a complete case analysis (listwise deletion) was performed, resulting in the exclusion of six participants from the final analysis.

Statistical Analysis

Data were screened and cleaned to ensure they met the necessary assumptions for statistical analysis. This process included an evaluation of missing data, outliers, multicollinearity, and distribution normality.

Descriptive statistics were computed, with continuous variables summarized using mean and standard deviation, and categorical variables using relative frequencies. For univariate analysis, the Chi square test was employed to compare groups. All variables showing a statistically significant association in the univariate analysis at a P<0.20 were included in the logistic regression models. This approach was used to identify factors associated with the outcomes while controlling for potential confounders. The threshold for statistical significance was set at P<0.05. All analyses were performed using SPSS software (version 26, SPSS Inc., USA).

Results

This study included 360 medical students, with a mean age of 22.62±3.02 years; 51.9% were men and 48.1% were women. Among the participants, 42.5% reported lifetime ASS use, while 33.6% reported ASS use within the past 3 months (table 1).

Variables n (%) N=360 Use during lifetime Use during the past 3 months
Yes n (%) No n (%) cOR (CI 95%) P value aOR (CI 95%) P value Yes n (%) No n (%) cOR (CI 95%) P value aOR (CI 95%) P value
Sex Female 173 (48.1) 62 (35.8) 111 (64.2) 1.0 0.014* 1.0 0.054 48 (27.7) 125 (72.3) 1.0 0.023* 1.0 0.70
Male 187 (51.9) 91 (48.7) 96 (51.3) 1.6 (1.1-2.5) 1.6 (0.9-2.7) 73 (39.0) 114 (61.0) 1.6 (1.1-2.5) 1.6 (0.9-2.7)
Stage of student Basic sciences 188 (52.2) 65 (34.6) 123 (65.4) 1.0 0.014* 1.0 <0.001* 52 (27.7) 136 (72.3) 1.0 <0.001* 1.0 0.002*
Pre-clinic 95 (26.4) 37 (38.9) 58 (61.1) 1.0 (0.6-1.8) 1.1 (0.6-2.0) 0.719 28 (29.5) 67 (70.5) 1 (0.6-1.8) 1 (0.5-1.8) 0.989
Clinic 77 (21.4) 51 (66.2) 26 (33.8) 2.9 (1.7-5.1) 3.4 (1.7-6.7) <0.001* 41 (53.2) 36 (46.8) 2.9 (1.7-5.1) 2.9 (1.5-5.5) 0.001*
Living place With parents 176 (48.9) 76 (43.2) 100 (56.8) 1.0 0.798 58 (33.0) 118 (67.0) 1.0 0.796
Dormitory 184 (51.1) 77 (41.8) 107 (58.2) 0.9 (0.6-1.4) 63 (34.2) 121 (65.8) 1.1 (0.6-1.6)
Being native Yes 169 (46.9) 77 (45.6) 92 (54.4) 1.0 0.269 58 (34.3) 111 (65.7) 1.0 0.789
No 191 (53.1) 76 (39.8) 115 (60.2) 0.7 (0.5-1.2) 63 (33.0) 128 (67.0) 0.9 (0.6-1.4)
Family economic status Lower than average 14 (3.9) 7 (50.0) 7 (50.0) 1.0 0.045* 1.0 0.040* 4 (28.6) 10 (71.4) 1.0 0.726
Average level 262 (72.8) 101 (38.5) 161 (61.5) 0.6 (0.2-1.8) 0.7 (0.2-2.3) 0.571 86 (32.8) 176 (67.2) 1.2 (0.3-4)
Higher than average 84 (23.3) 45 (53.6) 39 (46.4) 1.1 (0.3-3.5) 1.5 (0.4-5.3) 0.518 31 (36.9) 53 (63.1) 1.4 (0.4-5)
Family quarrel Low 126 (35.0) 48 (38.1) 78 (61.9) 1.0 0.215 . . 36 (28.6) 90 (71.4) 1.0 0.137 1.0 0.613
High 234 (65.0) 105 (44.9) 129 (55.1) 1.3 (0.8-2.1) 85 (36.3) 149 (63.7) 1.4 (0.8-2.2) 1.1 (0.6-2.0)
Family support Low 77 (21.4) 44 (57.1) 33 (42.9) 1.0 0.003* 1.0 0.110 35 (45.5) 42 (54.5) 1.0 0.013* 1.0 0.247
High 283 (78.6) 109 (38.5) 174 (61.5) 0.4 (0.2-0.7) 0.6 (0.3-1.1) 86 (30.4) 197 (69.6) 0.5 (0.3-0.8) 0.6 (0.3-1.2)
Recent mental illness Never 74 (20.6) 21 (28.4) 53 (71.6) 1.0 0.010* 1.0 0.125 17 (23.0) 57 (77.0) 1.0 0.016* 1.0 0.134
Moderate 203 (56.4) 89 (43.8) 114 (56.2) 1.9 (1.1-3.5) 1.7 (0.8-3.5) 0.118 67 (33.0) 136 (67.0) 1.6 (0.8-3) 1.4 (0.6-2.9) 0.345
High 83 (23.1) 43 (51.8) 40 (48.2) 2.7 (1.3-5.2) 2.3 (1.03-5.3) 0.042* 37 (44.6) 46 (55.4) 2.6 (1.3-5.3) 2.3 (0.9-5.4) 0.055
History of ASS use in the family No 284 (78.9) 104 (36.6) 180 (63.4) 1.0 <0.001* 1.0 0.107 78 (27.5) 206 (72.5) 1.0 <0.001* 1.0 0.048*
Yes 76 (21.1) 49 (64.5) 27 (35.5) 3.1 (1.8-5.3) 1.6 (0.8-3.1) 43 (56.6) 33 (43.4) 3.4 (2-5.8) 1.8 (1.02-3.3)
History of ASS use in friends No 150 (41.7) 36 (24.0) 114 (76) 1.0 <0.001* 1.0 <0.001* 24 (16.0) 126 (84.0) 1.0 <0.001* 1.0 <0.001*
Yes 210 (58.3) 117 (55.7) 93 (44.3) 3.9 (2.5-6.3) 4 (2.2-7.2) 97 (46.2) 113 (53.8) 4.5 (2.6-7.5) 4.1 (2.2-7.5)
Satisfaction with major Very satisfied 138 (38.3) 52 (37.7) 86 (62.3) 1.0 0.008* 1.0 0.060 43 (31.2) 95 (68.8) 1.0 0.022* 1.0 0.126
Satisfaction on an average level 165 (45.8) 66 (40.0) 99 (60.0) 1.1 (0.6-1.7) 0.8 (0.5-1.5) 0.642 49 (29.7) 116 (70.3) 0.9 (0.5-1.5) 0.7 (0.4-1.2) 0.261
Partly unsatisfied 37 (10.3) 25 (67.6) 12 (32.4) 3.4 (1.5-7.4) 3 (1.1-7.8) 0.020* 20 (54.1) 17 (45.9) 2.5 (1.2-5.4) 1.9 (0.7-4.7) 0.163
Completely unsatisfied 20 (5.6) 10 (50.0) 10 (50.0) 1.6 (0.6-4.2) 1.2 (0.3-3.7) 0.727 9 (45.0) 11 (55.0) 1.8 (0.6-4.6) 1.4 (0.4-4.3) 0.555
Physical activity Inactive 78 (21.7) 37 (47.4) 41 (52.6) 1.0 0.147 1.0 0.763 27 (34.6) 51 (65.4) 1.0 0.397
Moderate 234 (65.0) 91 (38.9) 143 (61.1) 0.7 (0.4-1.1) 0.7 (0.4-1.4) 0.462 74 (31.6) 160 (68.4) 0.8 (0.5-1.5)
Active 48 (13.3) 25 (52.1) 23 (47.9) 1.2 (0.5-2.4) 0.8 (0.3-1.9) 0..682 20 (41.7) 28 (58.3) 1.3 (0.6-2.8)
Sleep Appropriate 238 (66.1) 98 (41.2) 140 (58.8) 1.0 0.478 74 (31.1) 164 (68.9) 1.0 0.158 1.0 0.934
Inappropriate 122 (33.9) 55 (45.1) 67 (53.9) 1.1 (0.7-1.8) 47 (38.5) 75 (61.5) 1.3 (0.8-2.1) 1.0 (0.5-1.8)
Electronic device and social network use Appropriate 214 (59.4) 77 (36.0) 137 (64.0) 1.0 0.002* 1.0 0.133 57 (26.6) 157 (73.4) 1.0 <0.001* 1.0 0.043*
Inappropriate 146 (40.6) 76 (52.1) 70 (47.9) 1.9 (1.2-2.9) 1.4 (0.8-2.4) 64 (43.8) 82 (56.2) 2.1 (1.3-3.3) 1.7 (1.01-2.9)
*Factors that were statistically significant (P<0.05); cOR=Crude odds ratio; aOR=Adjusted odds ratio; ASS: Alcohol, smoking, and substance
Table 1.The frequency of alcohol, smoking, and substance (ASS) use during lifetime and the past 3 months according to demographic characteristics of medical students

Chi square tests revealed several factors positively associated with lifetime ASS use: male sex (P=0.014), clinical stage of training (P=0.014), high family economic status (P=0.045), low family support (P=0.003), a recent history of mental illness (P=0.010), a positive history of ASS use among family and friends (P<0.001), being completely unsatisfied with their major (P=0.008), and inappropriate use of electronic devices and social networks (P=0.002).

Similarly, factors associated with ASS use in the past 3 months included: male sex (P=0.023), clinical stage of training (P<0.001), low family support (P=0.013), a recent history of mental illness (P=0.016), a positive history of ASS use among family and friends (P<0.001), inappropriate use of electronic devices and social networks (P<0.001), and being completely unsatisfied with their major (P=0.022, table 1).

Logistic regression analyses were performed, including all variables significantly associated with ASS use in the univariate analyses at P<0.20. According to the results, being in the clinical stage (OR=3.4, 95% CI: 1.7-6.7), having a lower family economic status (OR=2.38, 95% CI: 1.2-4.6), a recent history of mental illness (OR=2.3, 95% CI: 1.03-5.3), a positive history of ASS use among friends (OR=4, 95% CI: 2.2-7.2), and being partly unsatisfied with their major (OR=3, 95% CI: 1.1-7.8), were all positively associated with lifetime ASS use (P<0.05).

For ASS use in the past 3 months, the positively associated factors (P<0.05) were: being in the clinical stage (OR=2.9, 95% CI: 1.5-5.5), a positive history of ASS use among friends (OR=4.1, 95% CI: 2.2-7.5), family members (OR=1.8, 95% CI: 1.02-3.3), and inappropriate use of electronic devices and social networks (OR=1.7, 95% CI: 1.01-2.9; table 1).

Table 2 presents the risk categories and the frequency distribution of ASS use among medical students. Figure 1 illustrates the prevalence of specific substances used over their lifetime and in the past 3 months, indicating the highest prevalence for alcoholic beverages, tobacco products, and electronic cigarettes. Figure 2 shows the variation in ASS use across academic years, with the highest rates observed in the seventh year.

Substance Risk category n (%) Use during lifetime n (%) Use during the past 3 months n (%)
Never Once or twice Monthly Weekly Daily or almost daily Total
Tobacco products Lower risk 290 (80.6) 96 (26.7) 282 (78.3) 40 (11.1) 12 (3.3) 12 (3.3) 14 (3.9) 78 (21.6)
Moderate risk 69 (19.2)
High risk 1 (0.3)
Opioids Lower risk 355 (98.6) 11 (3.1) 354 (98.3) 6 (1.7) 0 (0.0) 0 (0.0) 0 (0.0) 6 (1.7)
Moderate risk 5 (1.4)
High risk 0 (0.0)
Cannabis Lower risk 353 (98.1) 11 (3.1) 349 (96.9) 8 (2.2) 3 (0.8) 0 (0.0) 0 (0.0) 11 (3.0)
Moderate risk 7 (1.9)
High risk 0 (0.0)
Amphetamine-type stimulants Lower risk 354 (98.3) 8 (2.2) 355 (98.6) 4 (1.1) 1 (0.3) 0 (0.0) 0 (0.0) 5 (1.4)
Moderate risk 6 (1.7)
High risk 0 (0.0)
Sedatives or sleeping pills Lower risk 337 (93.6) 52 (14.4) 327 (90.8) 22 (6.1) 4 (1.1) 5 (1.4) 2 (0.6) 33 (9.2)
Moderate risk 23 (6.4)
High risk 0 (0.0)
Alcohol beverages Lower risk 347 (96.4) 99 (27.5) 291 (80.9) 41 (11.4) 26 (7.2) 2 (0.6) 0 (0.0) 69 (19.2)
Moderate risk 13 (3.6)
High risk 0 (0.0)
Inhalants Lower risk 355 (98.6) 10 (2.8) 355 (98.6) 1 (0.3) 3 (0.8) 1 (0.3) 0 (0.0) 5 (1.4)
Moderate risk 5 (1.4)
High risk 0 (0.0)
Hallucinogens Lower risk 358 (99.4) 3 (0.8) 359 (99.7) 1 (0.3) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.3)
Moderate risk 2 (0.6)
High risk 0 (0.0)
Cocaine Lower risk 357 (99.2) 2 (0.6) 360 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Moderate risk 3 (0.8)
High risk 0 (0.0)
Others Lower risk 360 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Moderate risk 0 (0.0)
High risk 0 (0.0)
Electronic cigarettes and vape 57 (15.8) 320 (88.9) 18 (5.0) 8 (2.2) 7 (1.9) 7 (1.9) 40 (11.1)
Table 2.Risk category and frequency distribution of alcohol, smoking, and substance (ASS) use among medical students

Figure 1. The diagram shows the frequency distribution of alcohol, smoking, and substance (ASS) use among medical students during their lifetime and the past 3 months.

Figure 2. The diagram shows the prevalence of alcohol, smoking, and substance (ASS) use during lifetime and the past 3 months, which was assessed according to the duration of the academic study.

Additionally, the demographic and key characteristics of medical students were examined in relation to cigarette and alcohol use over their lifetime and in the past 3 months, utilizing the Chi square test and logistic regression.

For cigarette use, Chi square tests indicated that low family support (P=0.014 for lifetime and P=0.049 for past 3 months), recent mental health issues (P=0.011 for lifetime and P=0.002 for past 3 months), and a history of substance use among family (P<0.001 for both lifetime and past 3 months) and friends (P<0.001 for both lifetime and past 3 months) were significantly associated with both lifetime use and use in the past 3 months.

Furthermore, male sex (P=0.008), the student’s academic stage (P=0.029), and inappropriate use of electronic devices and social networks (P=0.015) were significantly associated with lifetime cigarette use, while poor sleep (P=0.041) was associated with cigarette use in the past 3 months.

For alcohol use, significant associations were found for male sex (P=0.003 for lifetime and P=0.013 for past 3 months), students’ academic stage (P<0.001 for lifetime and P=0.002 for past 3 months), a history of substance use among family (P<0.001 for both lifetime and past 3 months) and friends (P<0.001 for both lifetime and past 3 months), low physical activity (P=0.015 for lifetime and P=0.009 for past 3 months), and inappropriate use of electronic devices and social networks (P=0.004 for lifetime and P=0.013 for past 3 months). Additionally, higher family economic status was associated with lifetime alcohol consumption (P=0.044, table 3).

Variable Cigarette Alcohol
Use during lifetime Use during the past 3 months Use during lifetime Use during the past 3 months
User n (%) Non-user n (%) P value User n (%) Non-user n (%) P value User n (%) Non-user n (%) P value User n (%) Non-user n (%) P value
Sex Female 35 (20.2) 138 (79.8) 0.008* 30 (17.3) 143 (82.7) 0.055 35 (20.2) 138 (79.8) 0.003* 24 (13.9) 149 (86.1) 0.013*
Male 61 (32.6) 126 (67.4) 48 (25.7) 139 (74.3) 64 (34.2) 123 (65.8) 45 (24.2) 141 (75.8)
Stage of student Basic sciences 41 (21.8) 147 (78.2) 0.029* 35 (18.6) 153 (81.4) 0.071 40 (21.3) 148 (78.7) <0.001* 32 (17.0) 156 (83.0) 0.002*
Pre-clinic 26 (27.4) 69 (72.6) 19 (20.0) 76 (80.0) 22 (23.2) 73 (76.8) 12 (12.6) 83 (87.4)
Clinic 29 (37.7) 48 (62.3) 24 (31.2) 53 (68.8) 37 (48.1) 40 (51.9) 25 (32.9) 51 (67.1)
Living place With parents 45 (25.6) 131 (74.4) 0.645 35 (19.9) 141 (80.1) 0.423 48 (27.3) 128 (72.7) 0.925 30 (17.1) 145 (82.9) 0.330
Dormitory 51 (27.7) 133 (72.3) 43 (23.4) 141 (76.6) 51 (27.7) 133 (72.3) 39 (21.2) 145 (78.8)
Being native Yes 46 (27.2) 123 (72.8) 0.824 37 (21.9) 132 (78.1) 0.922 50 (29.6) 119 (70.4) 0.404 31 (18.3) 138 (81.7) 0.691
No 50 (26.2) 141 (73.8) 41 (21.5) 150 (78.5) 49 (25.7) 142 (74.3) 38 (20.0) 152 (80.0)
Economic status of the family Lower than average 5 (35.7) 9 (64.3) 0.181 4 (28.6) 10 (71.4) 0.252 3 (21.4) 11 (78.6) 0.044* 1 (7.1) 13 (92.9) 0.062
Average level 63 (24.0) 199 (76.0) 51 (19.5) 211 (80.5) 64 (24.4) 198 (75.6) 45 (17.2) 216 (82.8)
Higher than average 28 (33.3) 56 (66.7) 23 (27.4) 61 (72.6) 32 (38.1) 52 (61.9) 23 (27.4) 61 (72.6)
Family quarrel Low 26 (20.6) 100 (79.4) 0.058 21 (16.7) 105 (83.3) 0.091 27 (21.4) 99 (78.6) 0.058 20 (15.9) 106 (84.1) 0.237
High 70 (29.9) 164 (70.1) 57 (24.4) 177 (75.6) 72 (30.8) 162 (69.2) 49 (21.0) 184 (79.0)
Family support Low 29 (37.7) 48 (62.3) 0.014* 23 (29.9) 54 (70.1) 0.049* 27 (35.1) 50 (64.9) 0.094 16 (20.8) 61 (79.2) 0.695
High 67 (23.7) 216 (76.3) 55 (19.4) 288 (80.6) 72 (25.4) 211 (74.6) 53 (18.8) 229 (81.2)
Recent mental illness Never 12 (16.2) 62 (83.8) 0.011* 10 (13.5) 64 (86.5) 0.002* 13 (17.6) 61 (82.4) 0.084 11 (14.9) 63 (85.1) 0.444
Moderate 53 (26.1) 150 (73.9) 39 (19.2) 164 (80.8) 59 (29.1) 144 (70.9) 39 (19.3) 163 (80.7)
High 31 (37.3) 52 (62.7) 29 (34.9) 54 (65.1) 27 (32.5) 55 (67.5) 19 (22.9) 64 (77.1)
History of ASS use in the family No 61 (21.5) 233 (78.5) <0.001* 48 (16.9) 236 (83.1) <0.001* 67 (23.6) 217 (76.4) <0.001* 43 (15.1) 241 (84.9) <0.001*
Yes 35 (46.1) 41 (53.9) 30 (39.5) 46 (60.5) 32 (42.1) 44 (57.9) 26 (34.7) 49 (65.3)
History of ASS use in friends No 17 (11.3) 133 (88.7) <0.001* 12 (8) 138 (92) <0.001* 20 (13.3) 130 (86.7) <0.001* 9 (6.0) 141 (94.0) <0.001*
Yes 79 (37.6) 131 (62.4) 66 (31.4) 144 (68.6) 79 (37.6) 131 (62.4) 60 (28.7) 149 (71.3)
Major satisfaction Very satisfied 35 (25.4) 103 (74.6) 0.128 31 (22.5) 107 (77.5) 0.041* 37 (26.8) 101 (73.2) 0.201 27 (19.6) 111 (80.4) 0.234
Satisfaction on an average level 39 (23.6) 126 (76.4) 29 (17.6) 136 (82.4) 40 (24.2) 125 (75.8) 26 (15.9) 138 (84.1)
Partly unsatisfied 13 (35.1) 24 (64.9) 9 (24.3) 28 (75.7) 15 (40.5) 22 (59.5) 11 (29.7) 26 (70.3)
Completely unsatisfied 9 (45.0) 11 (55.0) 9 (45.0) 11 (55.0) 7 (35.0) 13 (65.0) 5 (25.0) 15 (75.0)
Physical activity Inactive 21 (26.9) 57 (73.1) 0.172 18 (23.1) 60 (76.9) 0.327 23 (29.5) 55 (70.5) 0.015* 13 (16.7) 65 (83.3) 0.009*
Moderate 57 (24.4) 177 (75.6) 46 (19.7) 188 (80.3) 55 (23.5) 179 (76.5) 39 (16.7) 194 (83.3)
Active 18 (37.5) 30 (62.5) 14 (29.2) 34 (70.8) 21 (43.8) 27 (56.3) 17 (35.4) 31 (64.6)
Sleep Appropriate 57 (23.9) 181 (76.1) 0.103 44 (18.5) 194 (81.5) 0.041* 65 (27.3) 173 (72.7) 0.911 45 (18.9) 193 (81.1) 0.833
Inappropriate 39 (32.0) 83 (68.0) 34 (27.9) 88 (72.1) 34 (27.9) 88 (72.1) 24 (19.8) 97 (80.2)
Electronic device and social network use Appropriate 47 (22.0) 167 (78.0) 0.015* 41 (19.2) 173 (80.8) 0.162 47 (22.0) 167 (78.0) 0.004* 32 (15.0) 182 (85.0) 0.013*
Inappropriate 49 (33.6) 97 (66.4) 37 (25.3) 109 (74.7) 52 (35.6) 94 (64.4) 37 (25.5) 108 (74.5)
*Factors that were statistically significant using Chi square test (P<0.05); ASS: Alcohol, smoking, and substance
Table 3.Demographic and key characteristics of the medical students by cigarette and alcohol use during the lifetime and past 3 months

Logistic regression models for cigarette and alcohol use included all variables with a univariate association at P<0.20 (table 4).

Variables Cigarette Alcohol
Use during lifetime Use during the past 3 months Use during lifetime Use during the past 3 months
Adjusted OR (95%CI) P value Adjusted OR (95%CI) P value Adjusted OR (95%CI) P value Adjusted OR (95%CI) P value
Sex (male) 1.8 (1.03-3.2) 0.032* 1.5 (0.8-2.7) 0.156 1.8 (1.02-3.3) 0.026* 1.4 (0.7-2.6) 0.262
Stage of student (clinic) 1.4 (0.6-2.9) 0.088 1.7 (0.7-3.8) 0.174 3.3 (1.5-3.6) 0.002* 3.8 (1.6-9.2) 0.003*
Economic status of the family (higher than average) 1.8 (0.9-3.4) 0.053 - - 1.9 (1.02-3.7) 0.025* 7.0 (0.8-61.9) 0.054
Family quarrel (high) 1.3 (0.7-2.4) 0.356 1.2 (0.6-2.4) 0.465 1.5 (0.8-2.8) 0.153 - -
Family support (high) 0.6 (0.3-1.2) 0.218 0.7 (0.3-1.4) 0.384 0.8 (0.4-1.6) 0.656 - -
Recent mental illness (high) 2.8 (1.1-7.1) 0.027* 2.2 (1.1-4.3) 0.016* 1.2 (0.6-2.4) 0.449 - -
History of ASS use in friends (yes) 3.9 (2.0-7.8) <0.001* 4.7 (2.2-10.1) <0.001* 3.6 (1.9-7.0) <0.001* 5.9 (2.6-13.4) <0.001*
History of ASS use in family (yes) 1.8 (1.01-3.5) 0.043* 2.0 (1.02-3.8) 0.029* 1.2 (0.6-2.3) 0.491 1.4 (0.7-2.8) 0.258
Major satisfaction (completely unsatisfied) 1.9 (0.5-6.8) 0.319 3.9 (1.0-14.7) 0.042* - - - -
Physical activity (high) 1.1 (0.4-2.8) 0.731 - - 2 (0.9-4.1) 0.060 2.2 (1.01-4.8) 0.041*
Sleep (inappropriate) 1.1 (0.6-2.1) 0.627 1.3 (0.7-2.4) 0.371 - - - -
Electronic device and social network use (inappropriate) 1.4 (0.8-2.5) 0.198 1.0 (0.5-1.9) 0.907 1.8 (1.01-3.2) 0.031* 1.9 (1.02-3.7) 0.032*
*Factors that were statistically significant in logistic regression analysis (P<0.05); ASS: Alcohol, smoking, and substance
Table 4.Logistic regression analysis of the relationship between cigarette and alcohol use during the lifetime and the past 3 months, and risk factors among medical students

For cigarette use, the analysis indicated that having a family member who uses cigarettes (lifetime OR=1.8, 95% CI: 1.01-3.5; past three months OR=2.0, 95% CI: 1.02-3.8), having a friend who uses cigarettes (lifetime OR=3.9, 95% CI: 2.0-7.8; past 3 months OR=4.7, 95% CI: 2.2-10.1), and a recent history of mental illness (lifetime OR=2.8, 95% CI: 1.1-7.1; past three months OR=2.2, 95% CI: 1.1-4.3) were positively associated with both lifetime use and use in the past three months. Additionally, being male (OR=1.8, 95% CI: 1.03-3.2) was associated with lifetime use, and being completely unsatisfied with their major (OR=1.8, 95% CI: 1.03-3.2) was associated with use in the past months (OR=3.9, 95% CI: 1.0-14.7).

For alcohol us, positive associations for both lifetime and past three-month use were found for: having a friend who uses alcohol (lifetime OR=3.6, 95% CI: 1.9-7.0; past three months OR=5.9, 95% CI: 2.6-13.4), being in the clinical stage (lifetime OR=3.3, 95% CI: 1.5-7.6; past three months OR=3.8, 95% CI: 1.6-9.2), and inappropriate use of electronic devices and social networks (lifetime OR=1.8, 95% CI: 1.01-3.2; past three months OR=1.9, 95% CI: 1.02-3.7). Furthermore, male sex (OR=1.8, 95% CI: 1.02-3.3) and a higher-than-average family economic status(OR=1.9, 95% CI: 1.02-3.7) were associated with lifetime use, while higher physical activity was associated with use in the past three months (OR=2.2, 95% CI: 1.01-4.8).

Discussion

This study found a substantial prevalence of ASS use among medical students, with approximately one in four reporting lifetime use of alcohol and cigarettes, and one in five for past 3 months use of alcohol and cigarettes. Logistic regression analyses identified several risk factors. For lifetime cigarette use, significant predictors included having a family member or friend who smokes, being male, and having a recent history of mental illness. For lifetime alcohol use, significant predictors were having a friend who uses alcohol, being male, being in the clinical stage of training, having a higher-than-average family economic status, and inappropriate use of electronic devices and social networks.

In this study, the lifetime prevalence was 27.5% for alcoholic beverages and 26.7% for tobacco products, representing the highest rates among all ASS types. Consequently, the prevalence of these specific substances was compared with findings from previous domestic and international studies. However, direct comparisons should consider variations in study design and definitions of “users”.

In Iran, previous studies reported a wide range of cigarette smoking prevalence among medical students, from 10.5% to 46.7%. 18 - 21 Similarly, an international study by Machowicz and colleagues found that the prevalence of smoking among medical students was 14% in Warsaw, 14.4% in Strasbourg, and 3.5% in Tehran. 22 These disparities could be attributed to a variety of factors, including cultural differences, socioeconomic status, and variations in healthcare access and smoking cessation programs. These findings highlighted the need to understand the specific reasons for smoking prevalence in this population and to implement tailored interventions.

In the present study, the reported lifetime alcohol consumption was higher than the rates reported in some studies conducted in Iran. 23 , 24 However, it was lower than the prevalence reported by Novin and others, who found 34%. 20 A comparison with international data showed that alcohol use prevalence was significantly higher among students outside Iran. For instance, studies by Gignon and colleagues, 25 and Merlo and colleagues, 26 reported prevalence rates of 97% and 96%, respectively. The disparity in prevalence rates inside and outside Iran might originate from Iran’s religious and legal restrictions on alcohol use. This underscored the importance of further research to accurately determine the true prevalence of alcohol consumption in the region.

It is also essential to contextualize our findings within southern Iran. A study conducted about two decades ago among medical students in this region demonstrated that 6.79% of males and 0.69% of females were smokers. 27 A comparison with our results indicated a marked increase in smoking prevalence, particularly among female students. This surge in prevalence might be attributed to evolving societal norms and heightened stress levels.

Furthermore, compared to a study among pre-university students in southern Iran, which reported a smoking prevalence of 15.3% among boys and 12.2% among girls, 28 our findings suggested a higher prevalence among university-level medical students. 28 This discrepancy might be ascribed to increased peer influence, easier access to cigarettes, and the use of smoking as a coping mechanism for stress among university students. In essence, aligning our findings with these regional studies offered valuable insights into the shifting patterns of smoking prevalence across different demographic and educational cohorts in southern Iran.

The present study found a significant association between a history of mental illnesses and ASS use among medical students. This relationship might be explained by the potential use of ASS as a maladaptive coping mechanism for managing stress, anxiety, or depression. Furthermore, individuals with emotional and psychological difficulties might exhibit a higher susceptibility to the addictive properties of nicotine, increasing the likelihood of smoking initiation and dependence. 11 These findings were consistent with previous research, which demonstrated a strong association between mental health issues and ASS use. 10

The implications of this relationship underscore the importance of addressing mental health concerns and implementing tailored smoking cessation interventions for medical students. By integrating support for psychological well-being with substance use prevention, healthcare professionals and institutions could better protect this critical population and mitigate associated health risks.

This study identified a significant relationship between lifetime ASS use and dissatisfaction with one’s major among medical students, a relationship that was particularly pronounced during the clinical stages. This association might stem from the high levels of stress and pressure inherent to medical training, which could lead students to adopt ASS use as a coping mechanism. 29 The demanding nature of medical education, characterized by long study hours and clinical responsibilities, often results in emotional exhaustion and burnout, further diminishing satisfaction with the chosen career path. 30

Addressing these underlying issues of burnout and major dissatisfaction is crucial for mitigating the risk of ASS use. Interventions such as structured stress reduction programs, accessible career counseling, and robust peer support systems could improve student well-being and academic satisfaction. By proactively tackling these root causes, medical institutions could potentially reduce ASS use related to academic distress and foster a healthier student population.

A significant association was also found between ASS use and having friends or family members who use ASS. This association could be attributed to social networks and peer pressure, where individuals adopt the behaviors of their immediate social circles. The normalization of ASS use within these networks further lowers barriers to initiation and sustained use. These findings were consistent with previous research underscoring the powerful influence of social networks on substance use behaviors. 10

Understanding this social dynamic is crucial for developing effective interventions. Public health initiatives should leverage this knowledge by implementing peer-led education and social network-based programs designed to modify social norms. Coupled with policies that promote healthy lifestyles, such strategies can effectively counteract the social influences that perpetuate ASS use, particularly among student populations.

The present study also identified a significant association between the use of electronic devices and social networks and ASS use among medical students. This relationship could be attributed to a variety of factors. First, extensive use of electronic devices and social media platforms could foster feelings of social isolation, anxiety, and stress, potentially leading students to adopt ASSs as a coping strategy. 31 Second, digital platforms could facilitate peer influence and normalize ASS use by increasing exposure and perceived acceptability. 32 Addressing this issue requires a multifaceted approach, including promoting digital wellness, fostering strong in-person support networks, and providing accessible mental health resources to help medical students manage stress effectively.

This investigation into the prevalence of risk factors of ASS use among medical students is particularly valuable given the inconsistent findings in previous studies. By providing detailed insights into the prevalence and associated factors, this research helps clarify this complex issue. Moreover, the substantial sample size strengthened the robustness of our findings. These contributions underscored the significance of this study in advancing knowledge and informing targeted prevention strategies for ASS use in this population.

This study had several limitations. First, the data were collected from a sample of medical students at a single university, and the use of a non-probability sampling method might limit the generalizability of the findings to other populations or geographic locations. Second, given the legal and social prohibitions on alcohol and narcotics in Iran, the fear of potential repercussions might have led to underreporting of ASS use, despite our measures to ensure anonymity. Finally, the cross-sectional design of this study precluded the establishment of causal relationships between the identified risk factors and ASS use.

Conclusion

This study revealed a concerning prevalence of ASS use among medical students. Significant associations were identified between ASS use and the student’s clinical stage, family economic status, a history of mental illness, ASS use among family and friends, inappropriate use of electronic devices and social networks, and dissatisfaction with their academic major. These findings emphasized the critical need for targeted interventions to reduce and prevent ASS use within this population. Furthermore, supportive interventions must be developed for students with a recent history of mental illness and for those whose social networks involve ASS use.

Acknowledgment

This study was extracted from an MPH thesis by Seyed Ali Mansouri. The authors gratefully acknowledge the Research Vice-Chancellor of Shiraz University of Medical Sciences (Shiraz, Iran) for their support of this study (grant number: 29641).

Authors’ Contribution

SA.M: Study concept, data acquisition, data analysis, and drafting; A.S: Study design, data interpretation, and reviewing the manuscript; M.SA: Data gathering and reviewing the manuscript; D.Sh: Data analysis and drafting the manuscript. All authors have read and approved the final manuscript and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Declaration of AI

We made use of the artificial intelligence model Sider (Version December 2024) to ensure the grammatical correctness of the sentences.

Conflicts of Interest

None declared.

References

  1. Varghese J, Muntode Gharde P. A Comprehensive Review on the Impacts of Smoking on the Health of an Individual. Cureus. 2023; 15:e46532. Publisher Full Text | DOI | PubMed [ PMC Free Article ]
  2. World Health Organization [Internet].. WHO Report on the Global Tobacco Epidemic, 2019: Offer Help to Quit Tobacco Use. c2019. [cited 1 Dec 2024]. Available from: https://www.who.int/publications/i/item/9789241516204
  3. LoConte NK, Brewster AM, Kaur JS, Merrill JK, Alberg AJ. Alcohol and Cancer: A Statement of the American Society of Clinical Oncology. J Clin Oncol. 2018; 36:83-93. DOI | PubMed
  4. Ilic M, Grujicic M, Novakovic B, Vrkatic A, Lozanov-Crvenkovic Z. Cigarette Smoking among Medical Students from the Western Balkan. Int J Environ Res Public Health. 2022; 19Publisher Full Text | DOI | PubMed [ PMC Free Article ]
  5. Moradinazar M, Najafi F, Jalilian F, Pasdar Y, Hamzeh B, Shakiba E, et al. Prevalence of drug use, alcohol consumption, cigarette smoking and measure of socioeconomic-related inequalities of drug use among Iranian people: findings from a national survey. Subst Abuse Treat Prev Policy. 2020; 15:39. Publisher Full Text | DOI | PubMed [ PMC Free Article ]
  6. Reitsma MB, Flor LS, Mullany EC, Gupta V, Hay SI, Gakidou E. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and initiation among young people in 204 countries and territories, 1990-2019. Lancet Public Health. 2021; 6:e472-e81. Publisher Full Text | DOI | PubMed [ PMC Free Article ]
  7. Baranski K, Szemik S, Kaleta-Pilarska A, Kowalska M. General health and its relation to the quality of life and alcohol consumption in a Polish cohort of medical students - preliminary results of POLLEK survey. Front Public Health. 2023; 11:1178124. Publisher Full Text | DOI | PubMed [ PMC Free Article ]
  8. Ceyhun HA. Psychiatric symptoms, current use of tobacco, alcohol, illicit drug, and poly-substance among medical students in Eastern Turkey. J Ethn Subst Abuse. 2022;1-28. DOI | PubMed
  9. Armoon B, Eslamian A, Sepahvand E, Bayani A, Ahounbar E, Zarepour P, et al. Substance use and associated factors among Iranian university students: a meta-analysis. Journal of Substance Use. 2022; 27:352-62. DOI
  10. Taheri E, Ghorbani A, Salehi M, Sadeghnia HR. Cigarette smoking behavior and the related factors among the students of mashhad university of medical sciences in iran. Iran Red Crescent Med J. 2015; 17:e16769. Publisher Full Text | DOI | PubMed [ PMC Free Article ]
  11. Fluharty M, Taylor AE, Grabski M, Munafo MR. The Association of Cigarette Smoking With Depression and Anxiety: A Systematic Review. Nicotine Tob Res. 2017; 19:3-13. Publisher Full Text | DOI | PubMed [ PMC Free Article ]
  12. Alqahtani JS, Aldhahir AM, Alanazi Z, Alsulami EZ, Alsulaimani MA, Alqarni AA, et al. Impact of Smoking Status and Nicotine Dependence on Academic Performance of Health Sciences Students. Subst Abuse Rehabil. 2023; 14:13-24. Publisher Full Text | DOI | PubMed [ PMC Free Article ]
  13. Kavousipour S, Noorafshan A, Pourahmad S, Dehghani-Nazhvani A. Achievement motivation level in students of Shiraz University of Medical Sciences and its influential factors. J Adv Med Educ Prof. 2015; 3:26-32. Publisher Full Text | PubMed [ PMC Free Article ]
  14. World Health Organization [Internet].. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST). c2010. [cited 01 Dec 2024]. Available from: https://www.who.int/publications/i/item/978924159938-2
  15. Humeniuk R, Ali R, Babor TF, Farrell M, Formigoni ML, Jittiwutikarn J, et al. Validation of the Alcohol, Smoking And Substance Involvement Screening Test (ASSIST). Addiction. 2008; 103:1039-47. DOI | PubMed
  16. Galanti MR, Rosendahl I, Wickholm S. The development of tobacco use in adolescence among “snus starters” and “cigarette starters”: an analysis of the Swedish “BROMS” cohort. Nicotine Tob Res. 2008; 10:315-23. DOI | PubMed
  17. Hooshyari Z, Sadralssadat J, Sadralssadat L. Estimation of validation and reliability of Screening Test of Tobacco, Alcohol and Addictive Drugs in Iran. Research on Addiction. 2013; 7:37-52.
  18. Jalilian F, Karami Matin B, Ahmadpanah M, Ataee M, Ahmadi Jouybari T, Eslami AA, et al. Socio-demographic characteristics associated with cigarettes smoking, drug abuse and alcohol drinking among male medical university students in Iran. J Res Health Sci. 2015; 15:42-6. PubMed
  19. Niu L, Liu Y, Luo D, Xiao S. Current Smoking Behavior Among Medical Students in Mainland China: A Systematic Review and Meta-Analysis. Asia Pac J Public Health. 2018; 30:610-23. Publisher Full Text | DOI | PubMed [ PMC Free Article ]
  20. Novin MH, Shokri S, Eslamdoust-Siahestalkhi F, Pourramzani A. Frequency of Smoking, Alcohol Consumption, and Substance Use in Relation to General Health Indicators in Guilan University of Medical Sciences. Addict Health. 2023; 15:266-74. Publisher Full Text | DOI | PubMed [ PMC Free Article ]
  21. Armani kian A, Fathi M, Moeen Z, Rostami B, Safavi SZA-A, Fakour E. Relationship of Tendency towards Substance Abuse with Spiritual and Psychological Well-being in Students of Zanjan University of Medical Sciences. Health, Spirituality and Medical Ethics. 2020; 7:59-67. DOI
  22. Machowicz R, Ciechanska J, Zycinska K, Mahboobi N, Wnekowicz E, Obrowski MH, et al. Medical students’ aptitude toward smoking in Warsaw, Strasbourg and Teheran. Adv Exp Med Biol. 2013; 755:195-202. DOI | PubMed
  23. Ghalhari M, Mehri A, Dehghani R, Tehrani A, Atoof F. Prevalence of alcohol use and associated factors among students of medical sciences in central Iran. Alcoholism and Drug Addiction/Alkoholizm i Narkomania. 2021; 34:143-52. DOI
  24. Mozafarinia R, Assarian M, Ziaaddini A. Prevalence of Substance Abuse among Students of Tehran University of Medical Sciences, Iran. Addict Health. 2017; 9:103-9. Publisher Full Text | PubMed [ PMC Free Article ]
  25. Gignon M, Havet E, Ammirati C, Traulle S, Manaouil C, Balcaen T, et al. Alcohol, cigarette, and illegal substance consumption among medical students: a cross-sectional survey. Workplace Health Saf. 2015; 63:54-63. DOI | PubMed
  26. Merlo LJ, Curran JS, Watson R. Gender differences in substance use and psychiatric distress among medical students: A comprehensive statewide evaluation. Subst Abus. 2017; 38:401-6. DOI | PubMed
  27. Ahmadi J, Khalili H, Jooybar R, Namazi N, Aghaei PM. Cigarette smoking among Iranian medical students, resident physicians and attending physicians. Eur J Med Res. 2001; 6:406-8. PubMed
  28. Khoramdad M, Gholami F, Alimohamadi Y, Alavi Z, Shafiei J, Firouzi A. Prevalence of lifetime smoking and its determinant factors in high school adolescents in Shiraz. Journal of Community Health Research. 2016; 5:90-7.
  29. Hiremath SB, Chaitra VHM, Mahesh D. Stress and substance use among undergraduate medical students in a Government medical college in Northern Karnataka. Telangana Journal of Psychiatry. 2020; 6:119-24. DOI
  30. Kajjimu J, Kaggwa MM, Bongomin F. Burnout and Associated Factors Among Medical Students in a Public University in Uganda: A Cross-Sectional Study. Adv Med Educ Pract. 2021; 12:63-75. Publisher Full Text | DOI | PubMed [ PMC Free Article ]
  31. Lepp A, Barkley JE, Karpinski AC. The relationship between cell phone use, academic performance, anxiety, and Satisfaction with Life in college students. Computers in Human Behavior. 2014; 31:343-50. DOI
  32. Romer D, Moreno M. Digital Media and Risks for Adolescent Substance Abuse and Problematic Gambling. Pediatrics. 2017; 140:S102-S6. Publisher Full Text | DOI | PubMed [ PMC Free Article ]